ebselen has been researched along with Liver Dysfunction in 2 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koyanagi, T | 1 |
| Nakamuta, M | 1 |
| Enjoji, M | 1 |
| Iwamoto, H | 1 |
| Motomura, K | 1 |
| Sakai, H | 1 |
| Nawata, H | 1 |
| Pritsos, CA | 1 |
| Sokoloff, M | 1 |
| Gustafson, DL | 1 |
2 other studies available for ebselen and Liver Dysfunction
| Article | Year |
|---|---|
The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Azoles; Formazans; Gram-Positive Bacterial Infections; | 2001 |
PZ-51 (Ebselen) in vivo protection against adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity.
Topics: Acetylcysteine; Animals; Antioxidants; Azoles; Body Weight; Chemical and Drug Induced Liver Injury; | 1992 |